HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

BMS-871

displayed robust in vivo efficacy in Notch-dependent leukemia and solid tumor xenograft models; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzazepines: 5
      - Benzodiazepines: 8452
        Benzodiazepinones
        BMS-871: 1

Experts

1.	Balog, Aaron: 1 article (05/2015)
2.	Cvijic, Mary Ellen: 1 article (05/2015)
3.	Dai, Jun: 1 article (05/2015)
4.	Gavai, Ashvinikumar V: 1 article (05/2015)
5.	Gill, Patrice: 1 article (05/2015)
6.	Gona, Kiran Babu: 1 article (05/2015)
7.	Guarino, Victor: 1 article (05/2015)
8.	Han, Wen-Ching: 1 article (05/2015)
9.	Hunt, John T: 1 article (05/2015)
10.	Kandula, Sathiah: 1 article (05/2015)

Related Diseases

1.	Neoplasms (Cancer) 05/01/2015 - "Optimization of this series led to the identification of BMS-871 (compound 30) which displayed robust in vivo efficacy in Notch-dependent leukemia and solid tumor xenograft models. "
2.	Leukemia 05/01/2015 - "Optimization of this series led to the identification of BMS-871 (compound 30) which displayed robust in vivo efficacy in Notch-dependent leukemia and solid tumor xenograft models. "

Related Drugs and Biologics

1.	compound 30